An NCI-designated Comprehensive Cancer Center
Mustafa Raoof
Young surgeon/scientist awarded for groundbreaking pancreatic cancer research
July 14, 2020 | by Maxine Nunes
Mustafa Raoof, M.D., a surgical oncologist and researcher specializing in gastrointestinal cancers at City of Hope, received the grants for his groundbreaking work on pancreatic cancer.
Research | Patient Care
Emotional Contagion COVID Makes Us Vulnerable
Cancer patients often 'retraumatized' by coronavirus: How to cope
July 13, 2020 | by Abe Rosenberg
Patients who had just learned to deal with the anxiety of cancer may feel upended by having to contend with a new health concern. City of Hope psychiatrist Mona Mojtahedzadeh, M.D., offers tips to regain a sense of calm and control amid the COVID-19 crisis.
Patient Care | COVID-19
breakthroughs - fountain
Fred Claire: Former Dodgers GM chronicles cancer journey in new book
July 6, 2020 | by Abe Rosenberg
After being treated for skin cancer that spread to his jaw at City of Hope, former Dodgers General Manager Fred Claire has become one of the institution’s biggest boosters. He discusses his care by "the greatest team of my lifetime" in a new book, "Extra Innings."
Patient Care
Microscopic cancer cell multiple red - large hi res
New study may revolutionize the way we detect cancer
July 1, 2020 | by Maxine Nunes
Once we identify the point where cells shift from normal to malignant, we can potentially stop the process before a malignant cell ever appears, according to research by City of Hope's Russell Rockne, Ph.D.
Alexey Danilov Bio
Data-driven scientist to help lead blood cancer effort
June 24, 2020 | by Abe Rosenberg
Alexey Danilov, M.D., Ph.D., is a world leader in the study and treatment of chronic lymphocytic leukemia and many forms of lymphoma, alongside displaying an engaging manner with patients and colleagues. He is the new associate director of the Toni Stephenson Lymphoma Center.
Study finds way to determine tumor response to immunotherapy
June 22, 2020 | by Katie Neith
Research by City of Hope scientists has found that the way a patient's immune cells react at the beginning of immunotherapy treatment may predict the subsequent effectiveness of the therapy. The findings could improve personalized medicine for cancer patients by determining at the outset who might benefit from the therapy.